Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as a sterile solution for injection for intra‑arterial, intra‑articular and intrathecal use. It enhances radiographic visibility of vascular and body spaces during diagnostic imaging procedures such as angiography, arthrography and myelography.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with distribution originating from the European Union market. All batches meet EU pharmacopoeial specifications and are shipped under controlled conditions.

Iomeron is an iodinated contrast agent used to improve X‑ray based imaging of vascular and body compartments.

Angiography: provides enhanced visualization of blood vessels, aiding diagnosis and guidance during interventional procedures. Arthrography: delineates joint structures, allowing assessment of cartilage, ligaments and menisci. Myelography: highlights the spinal canal and nerve roots, facilitating detection of spinal pathology.

Iomeron may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Warm sensation at injection site - Nausea - Metallic taste - Headache

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction - Acute kidney injury - Severe hypotension

Prior to administration of Iomeron, clinicians should evaluate patient-specific factors and follow handling guidelines to minimize risk. - Renal function assessment: verify adequate glomerular filtration before use. - History of iodine allergy: avoid or use pre‑medication in sensitised patients. - Thyroid disease: consider risk of iodine‑induced thyroid dysfunction. - Pregnancy and lactation: use only if essential, after risk‑benefit analysis. - Neonates and infants: adjust dose and monitor closely due to immature renal clearance. - Store at ambient temperature: keep in original container, protect from light and moisture.

Iomeron can interact with certain medicines, altering renal function or iodine handling; awareness of these interactions helps prevent complications.

Major Interactions (Avoid): - Metformin: risk of lactic acidosis in renal impairment; discontinue before contrast. - ACE inhibitors or ARBs: may exacerbate contrast‑induced nephropathy; hold therapy when appropriate. - Diuretics: can cause volume depletion, increasing renal risk.

Moderate Interactions (Monitor Closely): - NSAIDs: additive renal toxicity; monitor kidney function. - Thyroid hormone therapy: excess iodine may affect hormone levels; check thyroid status.